Actively Recruiting
Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative Metabolic Approach
Led by iIDEAS Group Holdings Limited · Updated on 2026-03-27
5
Participants Needed
1
Research Sites
75 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
English, Hindi and Gujarati
CONDITIONS
Official Title
Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative Metabolic Approach
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to give informed consent
- Male or female aged 25 to 65 years
- Body Mass Index (BMI) of 25 to less than 50
- Clinical diagnosis of type 2 diabetes mellitus by plasma glucose or A1C criteria
- Glycated Hemoglobin (HbA1c) between 7.5% and less than 10.5% within the past 3 months
- Currently taking oral combination therapy for type 2 diabetes
- At least 12 months of experience with diabetes self-management and support
You will not qualify if you...
- Pregnancy, breastfeeding, or planning pregnancy within 9-12 months
- Mentally or physically disabled, prisoner, or vulnerable individual
- Current participation in another research study or participation within past 30 days
- Current use of injected Glucagon Like Peptide 1 (GLP1) therapy
- American Society of Anesthesiologists (ASA) level 4 or higher
- History of severe hypoglycemia or hypoglycemia unawareness
- Evidence of type 1 diabetes or pancreatic exhaustion
- Unusual or challenging gastrointestinal anatomy or history of small bowel surgery
- Active or untreated H. pylori infection
- History of pancreatitis, active hepatitis, or active liver disease
- Symptomatic gallstones, kidney stones, or acute cholecystitis
- History of coagulopathy or upper gastrointestinal bleeding conditions
- Use of anticoagulation or P2Y12 inhibitors that cannot be stopped around procedure
- Serious diabetes complications including coronary artery disease or diabetic retinopathy
- Use of corticosteroids, GI motility drugs, or weight loss medications
- Persistent anemia (hemoglobin less than 10 g/dL)
- Severe kidney impairment (eGFR or MDRD less than 30 ml/min/1.73m2)
- Active systemic infection
- Chemotherapy within 9 months, recent abdominal radiation, or active malignancy within 5 years
- Active substance abuse or alcoholism
- Known sensitivities to medications used in the procedure
- Other serological markers associated with poor outcomes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AB Plus Speciality Hospital
Ahmedabad, Gujarat, India, 380054
Actively Recruiting
Research Team
P
Purvi A Chavda, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here